Evaluation of the specificity of [(18)F]fludarabine PET/CT in a xenograft model of follicular lymphoma: comparison with [(18)F]FDG and impact of rituximab therapy

BACKGROUND: [(18)F]Fludarabine is a novel positron emission tomography (PET) radiotracer for imaging lymphoma. The purpose of this preclinical study was to evaluate the robustness of [(18)F]fludarabine during rituximab therapy. In addition, a comparison was made between [(18)F]fludarabine and [(18)F...

Descripción completa

Detalles Bibliográficos
Autores principales: Hovhannisyan, Narinée, Guillouet, Stéphane, Fillesoye, Fabien, Dhilly, Martine, Patin, Delphine, Galateau, Françoise, Leporrier, Michel, Barré, Louisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414862/
https://www.ncbi.nlm.nih.gov/pubmed/25977881
http://dx.doi.org/10.1186/s13550-015-0101-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414862/
https://www.ncbi.nlm.nih.gov/pubmed/25977881
http://dx.doi.org/10.1186/s13550-015-0101-7

Ejemplares similares